IRIS
QUARTUCCIO, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.061
AS - Asia 6.563
EU - Europa 3.983
SA - Sud America 1.392
AF - Africa 140
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 8
AN - Antartide 1
Totale 25.157
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.885
SG - Singapore 3.150
CN - Cina 1.401
BR - Brasile 1.150
UA - Ucraina 1.055
HK - Hong Kong 769
DE - Germania 632
IT - Italia 590
VN - Vietnam 498
RU - Federazione Russa 358
FI - Finlandia 330
IE - Irlanda 240
SE - Svezia 218
GB - Regno Unito 213
TR - Turchia 162
IN - India 118
KR - Corea 111
CA - Canada 102
AR - Argentina 94
FR - Francia 70
AT - Austria 65
BD - Bangladesh 61
EC - Ecuador 50
ID - Indonesia 48
ZA - Sudafrica 47
MX - Messico 40
IQ - Iraq 38
JP - Giappone 38
PL - Polonia 36
NL - Olanda 33
CO - Colombia 30
CZ - Repubblica Ceca 27
ES - Italia 27
IR - Iran 27
EG - Egitto 21
TG - Togo 20
BE - Belgio 19
PY - Paraguay 19
CL - Cile 18
MA - Marocco 18
PK - Pakistan 17
LT - Lituania 16
UZ - Uzbekistan 14
AE - Emirati Arabi Uniti 13
TN - Tunisia 10
JO - Giordania 9
KZ - Kazakistan 9
PE - Perù 9
PT - Portogallo 9
SA - Arabia Saudita 9
VE - Venezuela 9
IL - Israele 8
KE - Kenya 8
TT - Trinidad e Tobago 8
AZ - Azerbaigian 7
BO - Bolivia 7
GR - Grecia 7
DO - Repubblica Dominicana 6
EE - Estonia 6
EU - Europa 6
JM - Giamaica 6
LB - Libano 6
MY - Malesia 6
NP - Nepal 6
UY - Uruguay 6
CR - Costa Rica 5
LK - Sri Lanka 5
NZ - Nuova Zelanda 5
OM - Oman 5
RO - Romania 5
AL - Albania 4
KG - Kirghizistan 4
TW - Taiwan 4
AU - Australia 3
BN - Brunei Darussalam 3
BY - Bielorussia 3
CH - Svizzera 3
DZ - Algeria 3
HR - Croazia 3
PH - Filippine 3
BB - Barbados 2
BH - Bahrain 2
BW - Botswana 2
CI - Costa d'Avorio 2
CY - Cipro 2
DK - Danimarca 2
ET - Etiopia 2
GA - Gabon 2
KW - Kuwait 2
LV - Lettonia 2
NO - Norvegia 2
PA - Panama 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
DM - Dominica 1
GE - Georgia 1
Totale 25.136
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.633
Singapore 1.172
Ann Arbor 1.122
Fairfield 1.061
Houston 964
Ashburn 939
Beijing 802
Chandler 767
Hong Kong 757
Jacksonville 680
Wilmington 519
Seattle 438
Dearborn 414
Boardman 352
Cambridge 335
Dublin 236
Princeton 229
Los Angeles 199
Udine 177
Ho Chi Minh City 156
Dallas 148
Izmir 138
Hefei 129
São Paulo 112
Buffalo 111
Seoul 105
Redondo Beach 97
Des Moines 83
Dong Ket 80
San Diego 79
Munich 78
Hanoi 74
Nuremberg 67
Ogden 60
New York 59
Norwalk 50
Ottawa 43
Redmond 41
Nanjing 38
London 36
Milan 35
Rio de Janeiro 34
Santa Clara 34
Warsaw 33
Mumbai 28
Frankfurt am Main 27
Johannesburg 27
Trieste 27
Belluno 26
San Mateo 26
Brooklyn 25
Lappeenranta 25
Atlanta 24
Belo Horizonte 24
Düsseldorf 24
Stockholm 24
Tokyo 24
Helsinki 23
Phoenix 23
Chennai 22
Denver 22
Montreal 22
Brasília 21
Brno 21
Curitiba 21
Vienna 21
Lomé 20
Toronto 20
Turku 19
Brussels 18
Guayaquil 18
Amsterdam 17
Da Nang 17
Guangzhou 17
Quito 17
Biên Hòa 16
Kunming 16
Rome 16
Auburn Hills 15
Boston 15
Chicago 15
Falls Church 15
Haiphong 15
Lauterbourg 15
Porto Alegre 15
Salvador 15
Goiânia 14
Ribeirão Preto 14
Tashkent 14
Baghdad 13
Orem 13
Augusta 12
Campinas 12
Mexico City 12
Poplar 12
Shanghai 12
Simi Valley 12
Buenos Aires 11
Grafing 11
Hyderabad 11
Totale 15.747
Salva come PNG Salva come JPEG
Nome #
Efficacy and safety of belimumab in primary Sjogren's syndrome: results of the BELISS open-label phase II study. 185
Differentiation between early rheumatoid and early psoriatic arthritis by the ultrasonographic study of the synovio-entheseal complex of the small joints of the hands 174
Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study. 171
Validation of the classification criteria for cryoglobulinaemic vasculitis. 170
Pain management in cryoglobulinaemic syndrome 169
Gitelman syndrome disclosed by calcium pyrophosphate deposition disease: Early diagnosis by ultrasonographic study 168
AB0695 Anti-prothrombin/phosphatidyl-serine complex autoantibodies in antiphospholipid syndrome: Preliminary data using a new ELISA method 163
A randomized controlled trial of rituximab for treatment of severe cryoglobulinemic vasculitis. 160
Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients 159
Pachydermodactyly: The role of ultrasonography and dermoscopy for diagnosis 159
Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study 158
A randomized, controlled, multicenter phase iii study of the efficacy and safety of rituximab (rtx) monotherapy versus the best available treatment (bat) in patients with mixed cryoglobulinemia syndrome (MC) Ann Rheum Dis 2010;69(Suppl3):93 157
The CC homozygosis of the -174G>C IL-6 polymorphism predicts a lower efficacy of rituximab therapy in rheumatoid arthritis 156
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group 154
Accuracy of Computer-Guided Flapless Implant Surgery in Fully Edentulous Arches and in Edentulous Arches With Fresh Extraction Sockets 154
Prevalence of mixed cryoglobulinaemia syndrome and circulating cryoglobulins in a population-based survey: the Origgio study. 151
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis 151
Use of teriparatide in osteoporosis due to active rheumatic diseases 150
Treatment with belimumab restores B cell subsets and their expression of B cell activating factor receptor in patients with primary Sjogren's syndrome 149
Acetaminophen-induced liver injury in a woman with febrile flare of systemic lupus erythematosus 149
Cryoglobulinaemia related to Sjogren's syndrome or HCV infection: differences based on the pattern of bone marrow involvement, lymphoma evolution and laboratory tests after parotidectomy. 148
Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sjögren's syndrome: results of a large multicentre study. 148
A B-cell activating factor receptor (BAFF-R) His159Tyr mutation in Sjögren's Syndrome related lymphoproliferation 147
Therapeutic options after treatment failure in rheumatoid arthritis or spondyloarthritides. 145
Increased genomic instability following treatment with direct acting anti-hepatitis C virus drugs 145
HCV-related liver and lymphoproliferative diseases: Association with polymorphisms of IL28B and TLR2 144
Optimizing the dose of mycophenolate mofetil for the maintenance treatment of lupus nephritis by therapeutic drug monitoring. 142
Efficacy of intravenous cyclosporine in a case of cytophagic histiocytic panniculitis complicated by haemophagocytic syndrome after visceral leishmania infection 142
Strontium ranelate and femural fracture healing during rheumatoid arthritis and osteoporosis 141
BLyS upregulation in Sjogren's syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands 141
Retrospective analysis of the usefulness of a protocol with high-dose methotrexate in polymyalgia rheumatica: Results of a single-center cohort of 100 patients 141
Patient-reported impact of spondyloarthritis on work disability and working life: The ATLANTIS survey 140
Atypical lymphoproliferation progressing into B-cell lymphoma in rheumatoid arthritis treated with different biological agents: clinical course and molecular characterization. 140
The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre study. 140
Cost-effectiveness analysis of two Rituximab retreatment regimens for longstanding rheumatoid arthritis. 139
A randomized, controlled, multicenter phase III study of the efficacy and safety of rituximab (rtx) monotherapy versus the best available treatment (bat) in patients with mixed cryoglobulinemia syndrome (MC) 138
Development of the ClinESSDAI: A clinical score without biological domain. A tool for biological studies 138
Apheresis treatment of cryoglobulinemic vasculitis: A multicentre cohort study of 159 patients 138
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study 136
Treatment of rheumatoid arthritis with rituximab: an update and possible indications. 135
Italian consensus recommendations for the management of hepatitis C infection in patients with rheumatoid arthritis 135
Rituximab monotherapy, rather than rituximab plus antiviral drugs, for initial treatment of severe hepatitis C virus-associated mixed cryoglobulinemia syndrome: comment on the article by Terrier et al 134
Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis 134
Anti-SSA/SSB-negative Sjögren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution 134
Role e of oral cyclophosphamide in the treatment of giant cell arteritis 132
Sequential therapy with belimumab followed by rituximab in Sjögren's syndrome associated with B-cell lymphoproliferation and overexpression of BAFF: evidence for long-term efficacy. 132
Introducing treat-to-target strategies of autoimmune extrahepatic manifestations of chronic hepatitis C virus infection 132
L. Quartuccio, M. Fabris, M. Maset, E. Pontarini, A. Zabotti, S. De Vita Bone marrow b-cell expansion in mixed cryoglobulinemia: association with nephritis and response to rituximab 130
B lymphocyte stimulator (BLyS) and monocytes: possible role in autoimmune diseases with a particular reference to rheumatoid arthritis 130
Dermoscopy of nail fold and elbow in the differential diagnosis of early psoriatic arthritis sine psoriasis and early rheumatoid arthritis 129
Classification of cryoglobulinemic vasculitis 128
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 127
Mycophenolic Acid AUC estimation in patients with lupus nephritis using an algorithm validated in an heart transplanted population 126
Cardiovascular disease risk burden in primary Sjögren's syndrome: results of a population-based multicentre cohort study. 124
Comment on: Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis: reply 123
Gastrointestinal Involvement in Systemic Vasculitis 122
Pregnancy and fetal outcome in patients with an established diagnosis of primary sjögren's syndrome 121
Myositis in primary sjögren's syndrome: data from a multicenter cohort 121
A retrospective, multicenter study evaluating the prognostic value of minor salivary gland histology in a large cohort of patients with primary Sjögren's syndrome. 121
Variations in lumbar and femural bmd after rituximab therapy in active rheumatoid arthritis 121
Efficacy and tolerability of repeated cycles of a once-weekly regimen of bortezomib in lupus. 121
Long-term Efficacy of Interferon-Free Antiviral Treatment Regimens in Patients With Hepatitis C Virus-Associated Cryoglobulinemia Vasculitis 121
A TGF-β associated genetic score to define prognosis and platinum sensitivity in advanced epithelial ovarian cancer 121
Development of type II mixed cryoglobulinaemic syndrome after effective and persistent hepatitis C virus eradication. 120
Late relapses of hepatitis C virus-cured mixed cryoglobulinaemia associated with infection or cancer 119
Pleuritis is a red flag for Adult-onset Still's disease which may require biologic therapies. 118
Type I interferon signature may influence the effect of belimumab on immunoglobulin levels, including rheumatoid factor in Sjögren's syndrome 118
HCV-unrelated cryoglobulinaemic vasculitis: the results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC) 117
A clinical-genetic score to identify surgically resected colorectal cancer patients benefiting from an adjuvant fluoropyrimidine-based therapy 116
Ultrasonographic detection of subclinical enthesitis and synovitis: a possible stratification of psoriatic patients without clinical musculoskeletal involvement 116
A randomized, controlled, multicenter phase III study of the efficacy and safety of Rituximab (RTX) monotherapy versus thebest available treatment in patients with mixedcryoglobulinemia syndrome, on behalf of the rituximab studygroup in cryoglobulinemic sindrome. 115
Fetal Outcome in Patients with an Established Diagnosis of Primary Sjögren’s Syndrome 113
Rituximab as possible first-line therapy for glomerulonephritis in HCV-related mixed cryoglobulinaemia 113
Preliminary classification criteria for the cryoglobulinaemic vasculitis 113
Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients 113
Safety of Rituximab in different rheumatic autoimmune diseases. A single centre experience in 85 cases. 2008 112
B-Lymphocyte Stimulator (BLyS) in mixed cryoglobulinemia sindrome: pathobiological and clinical implication 112
The role of the il-6 promoter p in predicting rituximab efficacy in rheumatoid artolymorphism 112
Clinical characterization and treatment outcome in a monocentric cohort of 45 patients with adult onset still's disease 112
Articular and peripheral nervous system involvement are linked to the long-term outcome in primary Sjögren's syndrome: The relevance of single organ manifestations rather than a composite score as predictors 112
Ciclosporina e tacrolimus nella miosite da corpi inclusi: efficacia clinica, sicurezza e risparmio nell'uso dei corticosteroidi 111
Efficacy of cyclosporin-A in the long-term management of thrombocytopenia associated with systemic lupus erythematosus 111
Efficacy of belimumab and targeting of rheumatoid factor-positive B-cell expansion in Sjögren's syndrome: follow-up after the end of the phase II open-label BELISS study 111
Delayed Positivization of Cerebral Angiography in Reversible Cerebral Vasoconstriction Syndrome (RCVS) Presenting with Recurrent Subarachnoid Haemorrhage. 111
Gastrointestinal involvement in systemic vasculitis 110
Long-term efficacy and improvement of health-related quality of life in patients with Takayasu's arteritis treated with infliximab. 109
efficacy of methotrexate in polymyalgia rheumatica 109
Disappearance of bone marrow B cell clonal expansion in patients with type II hepatitis C virus-related cryoglobulinemic glomerulonephritis after clinical efficient rituximab therapy. 109
The-308 TNFα and the -174 IL-6 promoter polymorphisms associate with effective anti-TNFα treatment in seronegative spondyloarthritis 109
Rheumatoid factor positivity, a lower disability and a lower number of anti-tnf agents failed are associated with response to rituximab in rheumatoid arthritis 109
Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients 109
High prevalence of Chlamydophila psittaci subclinical infection in Italian patients with Sjögren's syndrome and parotid gland marginal zone B-cell lymphoma of MALT-type. 106
Efficacy of Belimumab On Non-Malignant Parotid Swelling and Systemic Manifestations of Sjo¨gren’s Syndrome: Results of the Beliss Study. 105
Association be tween B cell clonal expansion and glomerulonephritis in type cryoglobulinnaemia. 2007; 66 (Suppl. II): 121 104
Association between bone marrow B cell clonal expansion and glomerulonephritis in type II mixed cryoglobulinaemia 104
Early Psoriatic Arthritis Versus Early Seronegative Rheumatoid Arthritis: Role of Dermoscopy Combined with Ultrasonography for Differential Diagnosis 104
prevalence of chlamydophila psittaci subclinical infection in italian patients with rheumatoid arthritis: etiopathological and therapeutic implications 103
Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome: Results From an International Retrospective Multicenter Study 103
Association be tween B cell clonal expansion and glomerulonephritis in type cryoglobulinnaemia 102
Outcome of Pregnancy in Italian Patients with Primary Sjogren Syndrome. 101
Totale 13.045
Salva come PNG Salva come JPEG
Categoria #
all - tutte 108.785
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 108.785
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.712 0 0 0 0 0 275 67 258 527 84 325 176
2021/20221.678 62 173 89 138 44 48 91 109 25 235 369 295
2022/20232.035 248 95 38 221 208 544 35 147 296 38 77 88
2023/2024763 109 62 29 19 144 89 30 64 99 60 21 37
2024/20255.380 121 403 231 158 236 233 337 358 709 492 771 1.331
2025/20265.509 789 1.026 943 1.044 1.543 164 0 0 0 0 0 0
Totale 26.079